The characteristics of blood glucose fluctuations in patients with fulminant type 1 diabetes mellitus in the stable stage.

Abstract

OBJECTIVE:

The aim was to characterize blood glucose fluctuations in patients with fulminant type 1 diabetes (FT1DM) at the stable stage using continuous blood glucose monitoring systems (CGMSs).

SUBJECTS AND METHODS:

Ten patients with FT1DM and 20 patients with classic type 1 diabetes mellitus (T1DM) (the control group) were monitored using CGMSs for 72 hours.

RESULTS:

The CGMS data showed that the mean blood glucose (MBG), the standard deviation of the blood glucose (SDBG), the mean amplitude glycemic excursions (MAGE), the blood glucose areas and the percentages of blood glucose levels below 13.9 mmol/L were similar between the two groups. However, the percentage of blood glucose levels below 3.9 mmol/L was significantly higher in the FT1DM group compared to the T1DM group (p < 0.05). The minimum (Min) blood glucose level in the FT1DM group was significantly lower than that of the T1DM group (p < 0.05). Patients with FT1DM had severe dysfunction of the islet beta cells and alpha cells compared to patients with T1DM, as indicated by lower C-peptide values and higher glucagon/C-peptide values.

CONCLUSION:

In conclusion, patients with FT1DM at the stable stage were more prone to hypoglycemic episodes as recorded by CGMSs, and they had a greater association with severe dysfunction of both the beta and alpha islet cells compared to patients with T1DM.

• Authors: Jie Wang, Bing-Li Liu, Zheng Li, Hui-Qin Li, Rui Sun, Yun Hu, Kok-Onn Lee, Lei Ye, Xiao-Fei Su, Jian-Hua Ma
• Journal: Archives of endocrinology and metabolism (Arch Endocrinol Metab) Vol. 62 Issue 6 Pg. 585-590 ( 2018) ISSN: 2359-4292 [Electronic] Brazil
• PMID: 30624497 (Publication Type: Comparative Study, Journal Article)

Chemical References

• Blood Glucose
• C-Peptide
• Hypoglycemic Agents
• Insulin
• Glucagon

Topics

• Adult
• Blood Glucose (analysis, metabolism)
• Blood Glucose Self-Monitoring (methods)
• C-Peptide (blood)
• Case-Control Studies
• Diabetes Mellitus, Type 1 (blood)
• Female
• Glucagon (blood)
• Humans
• Hypoglycemic Agents (administration & dosage)
• Insulin (administration & dosage, blood)
• Male
• Middle Aged
• Reference Values
• Retrospective Studies
• Statistics, Nonparametric